VEGFA and age-related macular degeneration: No significant correlations were seen between age, sex, type of anti-VEGF agents, use or no use of anticoagulants, AMD subtype, symptom duration, DAs, baseline BCVA, CFT, thickness of the SMHs at the fovea, thickness of the hemorrhagic PEDs at the fovea, and the presence of hyperpigmented spots (P > 0.05 for all comparisons).